Selective HSP90β Inhibition Disrupts SREBP1-Associated Metabolic Signaling and Suppresses Ovarian Cancer Progression: A Pilot Study

Ovarian cancer progression is supported by metabolic interactions between tumor cells and the adipocyte-rich peritoneal microenvironment, which can be further altered by obesity. Sterol regulatory element-binding protein 1 (SREBP1), a master regulator of lipid metabolism, represents a potential therapeutic target in this setting. Because heat shock protein 90 (HSP90) regulates SREBP1 stability and processing, we investigated whether selective inhibition of HSP90β with NDNB25 could disrupt SREBP1-associated metabolic signaling and suppress ovarian cancer progression. In a diet-induced obesity model, NDNB25 significantly reduced overall tumor burden in both low-fat and high-fat diet mice and decreased adipocyte area within intra-tumoral, peri-tumoral, and surrounding visceral adipose regions. In human and murine ovarian cancer cells, NDNB25 altered SREBP1 protein abundance and produced concentration-dependent effects on cell viability. Transcriptomic analysis demonstrated negative enrichment of an SREBP1-associated lipogenic program across OVCAR5, OVCAR8, and ID8 cells, together with broader remodeling of lipid-metabolic, inflammatory, and tumor-associated signaling pathways. Analysis of gene expression data from human ovarian tumors further demonstrated a positive association between HSP90AB1 expression and SREBP1-associated lipogenic signaling. Collectively, these findings demonstrate that selective HSP90β inhibition suppresses ovarian cancer progression across lean and obese host environments and induces broad transcriptional remodeling of metabolic and tumor-associated pathways, including SREBP1-associated lipid metabolism, supporting HSP90β as a potential therapeutic target for metabolically adapted ovarian cancer.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-11-20
DOI
https://doi.org/10.3390/ijms272210460
Primary Topic
Cancer, Lipids, and Metabolism
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Selective HSP90β Inhibition Disrupts SREBP1-Associated Metabolic Signaling and Suppresses Ovarian Cancer Progression: A Pilot Study

Wanrui Wang, Gena M. Dominique, Mary Sharon Stack, Jing Yang et al.
1 links
International Journal of Molecular Sciences
Cancer, Lipids, and Metabolism
article

Selective HSP90β Inhibition Disrupts SREBP1-Associated Metabolic Signaling and Suppresses Ovarian Cancer Progression: A Pilot Study

Wanrui Wang, Gena M. Dominique, Mary Sharon Stack, Jing Yang, Brian S. J. Blagg, Emily Cronberger, JEFFREY JOHNSON, Terin D’Amico, Grace Wikenheiser, Brighton Strasiotto, Theresa Kerker, Caitlyn Breslin, Maia Oh, Ellen Crotzer, Sanket Mishra
article en

Abstract

Ovarian cancer progression is supported by metabolic interactions between tumor cells and the adipocyte-rich peritoneal microenvironment, which can be further altered by obesity. Sterol regulatory element-binding protein 1 (SREBP1), a master regulator of lipid metabolism, represents a potential therapeutic target in this setting. Because heat shock protein 90 (HSP90) regulates SREBP1 stability and processing, we investigated whether selective inhibition of HSP90β with NDNB25 could disrupt SREBP1-associated metabolic signaling and suppress ovarian cancer progression. In a diet-induced obesity model, NDNB25 significantly reduced overall tumor burden in both low-fat and high-fat diet mice and decreased adipocyte area within intra-tumoral, peri-tumoral, and surrounding visceral adipose regions. In human and murine ovarian cancer cells, NDNB25 altered SREBP1 protein abundance and produced concentration-dependent effects on cell viability. Transcriptomic analysis demonstrated negative enrichment of an SREBP1-associated lipogenic program across OVCAR5, OVCAR8, and ID8 cells, together with broader remodeling of lipid-metabolic, inflammatory, and tumor-associated signaling pathways. Analysis of gene expression data from human ovarian tumors further demonstrated a positive association between HSP90AB1 expression and SREBP1-associated lipogenic signaling. Collectively, these findings demonstrate that selective HSP90β inhibition suppresses ovarian cancer progression across lean and obese host environments and induces broad transcriptional remodeling of metabolic and tumor-associated pathways, including SREBP1-associated lipid metabolism, supporting HSP90β as a potential therapeutic target for metabolically adapted ovarian cancer.

International Journal of Molecular SciencesVol. 27(22)
University of Notre Dame (US), Mike and Josie Harper Cancer Research Institute (US)
Walther Cancer Foundation, Mike and Josie Harper Cancer Research Institute
Good health and well-being
Cancer, Lipids, and Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon